Related Experiment Video
Updated: Aug 17, 2026

Cellular Redox Profiling Using High-content Microscopy
Published on: May 14, 2017
[Erythema multiforme caused by saquinavir]
H Garat1, F el Sayed, M Obadia
1Département de Dermatologie, Vénéréologie et Allergologie, Centre Hospitalier Universitaire Purpan, Toulouse.
Background:
Saquinavir is a protease inhibitor used for the treatment of HIV infection. Adverse skin reactions have been rare. We report here the first case of erythema multiforme in a patient given saquinavir.
Case Report:
A 32-year-old man was seropositive for HIV and consulted due to the development of round maculo-papular lesions centered on a bulla and two erosive lesions of the palate five days after the introduction of saquinavir. Histology was compatible with erythema multiforme. After withdrawal of saquinavir, the skin and mucosal lesions regressed in 15 days, with no recurrence at 3 months.
Discussion:
Adverse skin reactions to saquinavir are exceptional (eruptions, pruritus). We describe here the first case of erythema multiforme caused by saquinavir (imputability criteria 12 BO). Due to the structural analogy of saquinavir with other protease inhibitors (indiravir, ritonavir, nelfinavir) it would be difficult to prescribe a compound of the same class.
Related Concept Videos
Drug toxicity: Idiosyncratic Reactions
Staphylococcal Skin Infections
Rocky Mountain Spotted Fever
Yellow Fever
Respiratory Syncytial Virus Disease
Hypersensitivity Reactions: Immune-Complex Reactions

